| 70.14 0.01 (0.01%) | 04-25 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 83.94 | 1-year : | 87.13 |
| Resists | First : | 71.86 | Second : | 74.59 |
| Pivot price | 69.12  |
|||
| Supports | First : | 67.44 | Second : | 56.11 |
| MAs | MA(5) : | 70.19 |
MA(20) : | 69.51  |
| MA(100) : | 66.07 |
MA(250) : | 62.11 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 69.8 |
D(3) : | 66.4 |
| RSI | RSI(14): 51.3 |
|||
| 52-week | High : | 75.3 | Low : | 52.9 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PBH ] has closed below upper band by 21.8%. Bollinger Bands are 36.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 70.43 - 70.71 | 70.71 - 70.95 |
| Low: | 68.45 - 68.8 | 68.8 - 69.1 |
| Close: | 69.54 - 70.11 | 70.11 - 70.59 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Thu, 25 Apr 2024
Jennison Associates LLC Sells 38,259 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Thu, 25 Apr 2024
Prestige Consumer Healthcare (PBH) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Zacks Investment Research
Thu, 25 Apr 2024
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results - GlobeNewswire
Tue, 23 Apr 2024
Prestige Consumer Healthcare Inc. to Post FY2024 Earnings of $4.33 Per Share, Zacks Research Forecasts (NYSE:PBH) - MarketBeat
Mon, 22 Apr 2024
Investors in Prestige Consumer Healthcare (NYSE:PBH) have seen stellar returns of 138% over the past five years - Simply Wall St
Fri, 19 Apr 2024
Here's Why You Should Retain Prestige Consumer (PBH) Stock Now - Zacks Investment Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 50 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 105.5 (%) |
| Shares Short | 1,730 (K) |
| Shares Short P.Month | 1,730 (K) |
| EPS | -1.62 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 32.24 |
| Profit Margin | -7.2 % |
| Operating Margin | 30.7 % |
| Return on Assets (ttm) | 6.1 % |
| Return on Equity (ttm) | -5 % |
| Qtrly Rev. Growth | 2.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 22.75 |
| EBITDA (p.s.) | 7.65 |
| Qtrly Earnings Growth | 1.8 % |
| Operating Cash Flow | 241 (M) |
| Levered Free Cash Flow | 176 (M) |
| PE Ratio | -43.57 |
| PEG Ratio | 1.9 |
| Price to Book value | 2.17 |
| Price to Sales | 3.08 |
| Price to Cash Flow | 14.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|